Colin
- Mar 9, 2023
- 1 min read

Building Capability for Clinical Pharmacology Research in Sub-Saharan Africa

Link to full text: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.695

Abstract:

A strong scientific rationale exists for conducting clinical pharmacology studies in target populations because local factors such as genetics, environment, comorbidities, and diet can affect variability in drug responses. However, clinical pharmacology studies are not widely conducted in sub-Saharan Africa, in part due to limitations in technical expertise and infrastructure. Since 2012, a novel public-private partnership model involving research institutions and a pharmaceutical company has been applied to developing increased capability for clinical pharmacology research in multiple African countries.

Recent Posts

See All

Fostering drug discovery and development in Africa

Link to full text (requires subscription): https://www.nature.com/articles/s41591-022-01885-1 Abstract: The H3D Centre is a South African-based academic translational research unit that has had many s

Needs-driven talent and competency development for the next generation of regulatory scientists

Link to full text: https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bcp.15020 Abstract Capacity building programmes for African regulators should link education, training and research with car

Clinical Pharmacology Worldwide: A Global Health Perspective

Link to full text: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.2274 Abstract: Low- and middle-income countries (LMICs) have the highest rates of mortality and morbidity globally, but lag beh